In a report released today, Joseph Pantginis from H.C. Wainwright maintained a Buy rating on Actinium Pharmaceuticals (ATNM – Research Report), ...

H.C. Wainwright raised the firm’s price target on Monopar Therapeutics (MNPR) to $40 from $22 and keeps a Buy rating on the shares. The firm ...

HC Wainwright decreased their Q3 2025 EPS estimates for shares of Applied Digital in a research note issued to investors on ...

Immunic Inc (IMUX) stock saw a modest uptick, ending the day at $0.95 which represents no change from the prior close of of $0.95. The stock opened at $0.98 and touched a low of $0.92 during the day, ...

HC Wainwright cut their FY2024 EPS estimates for Karyopharm Therapeutics in a research report issued on Wednesday, January ...

Charles Allen, CEO of BTCS, stated, " We are thrilled to collaborate with H.C. Wainwright and Freddy to share insights on the ...

H.C. Wainwright maintained a positive outlook on Axsome Therapeutics (NASDAQ:AXSM), reiterating a Buy stock rating with a ...

Fintel reports that on January 17, 2025, HC Wainwright & Co. downgraded their outlook for CECO Environmental (NasdaqGS:CECO) ...

Stock Trading Recap. On Tuesday, Microbot Medical Inc (MBOT) stock saw a modest uptick, ending the day at $1.82 which represents a slight increase of $ ...

On Friday, H.C. Wainwright reaffirmed its Buy rating and $50.00 price target for Akero Therapeutics (NASDAQ:AKRO), representing significant upside potential from the current trading price of $24.01.

If you want to stay updated on the latest options trades for SoundHound AI, Benzinga Pro gives you real-time options trades ...

On Thursday, H.C. Wainwright adjusted its price target for Galiano Gold (NYSE:GAU) shares, lowering it to $3.10 from the previous $4.60, while maintaining a Buy rating for the stock. The ...